GI
NVO

GAMMA Investing’s Novo Nordisk NVO Stock Holding History

GAMMA Investing’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$371K Sell
9,789
-3,182
-25% -$147K 0.01% 881
2026
Q2 		$622K Buy
12,971
+5,880
+83% +$253K 0.02% 557
2026
Q1 		$261K Sell
7,091
-2,152
-23% -$102K 0.01% 936
2025
Q4 		$470K Buy
9,243
+1,223
+15% +$62.5K 0.02% 552
2025
Q3 		$445K Sell
8,020
-1,103
-12% -$64.6K 0.02% 553
2025
Q2 		$630K Sell
9,123
-343
-4% -$23.3K 0.04% 402
2025
Q1 		$657K Buy
9,466
+1,605
+20% +$133K 0.05% 343
2024
Q4 		$676K Sell
7,861
-106
-1% -$11.5K 0.06% 290
2024
Q3 		$949K Buy
7,967
+817
+11% +$109K 0.09% 197
2024
Q2 		$1.02M Buy
7,150
+809
+13% +$107K 0.14% 127
2024
Q1 		$814K Buy
6,341
+856
+16% +$102K 0.17% 110
2023
Q4 		$629K Buy
+5,485
New +$542K 0.17% 97

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

GAMMA Investing's NVO Position: Q3 2026 in Review

GAMMA Investing reduced its Novo Nordisk (NVO) stake by 25% in Q3 2026, selling an estimated $147K and leaving 9,789 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #881.

GAMMA Investing first reported a position in NVO in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.02M in Q2 2024. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • GAMMA Investing held 9,789 shares of Novo Nordisk worth $371K as of Q3 2026.
  • GAMMA Investing sold 3,182 Novo Nordisk shares in Q3 2026, an estimated $147K.
  • Novo Nordisk made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #881 holding.
  • GAMMA Investing first reported a position in Novo Nordisk in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Novo Nordisk position peaked at $1.02M in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.